Genetically modified Streptococcus mutans for the prevention of dental caries
There are many examples of positive and negative interactions between different species of bacteria inhabiting the same ecosystem. This observation provides the basis for a novel approach to preventing microbial diseases called replacement therapy. In this approach, a harmless effector strain is per...
Gespeichert in:
Veröffentlicht in: | Antonie van Leeuwenhoek 2002-08, Vol.82 (1-4), p.361-366 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 366 |
---|---|
container_issue | 1-4 |
container_start_page | 361 |
container_title | Antonie van Leeuwenhoek |
container_volume | 82 |
creator | Hillman, Jeffrey D |
description | There are many examples of positive and negative interactions between different species of bacteria inhabiting the same ecosystem. This observation provides the basis for a novel approach to preventing microbial diseases called replacement therapy. In this approach, a harmless effector strain is permanently implanted in the host's microflora. Once established, the presence of the effector strain prevents the colonization or outgrowth of a particular pathogen. In the case of dental caries, replacement therapy has involved construction of an effector strain called BCS3-L1, which was derived from a clinical Streptococcus mutans isolate. Recombinant DNA technology was used to delete the gene encoding lactate dehydrogenase in BCS3-L1 making it entirely deficient in lactic acid production. This effector strain was also designed to produce elevated amounts of a novel peptide antibiotic called mutacin 1140 that gives it a strong selective advantage over most other strains of S. mutans. In laboratory and rodent model studies, BCS3-L1 was found to be genetically stable and to produce no apparent deleterious side effects during prolonged colonization. BCS3-L1 was significantly less cariogenic than wild-type S. mutans in gnotobiotic rats, and it did not contribute at all to the cariogenic potential of the indigenous flora of conventional Sprague-Dawley rats. And, its strong colonization properties indicated that a single application of the BCS3-L1 effector strain to human subjects should result in its permanent implantation and displacement over time of indigenous, disease-causing S. mutans strains. Thus, BCS3-L1 replacement therapy for the prevention of dental caries is an example of biofilm engineering that offers the potential for a highly efficient, cost effective augmentation of conventional prevention strategies. It is hoped that the eventual success of replacement therapy for the prevention of dental caries will stimulate the use of this approach in the prevention of other bacterial diseases. |
doi_str_mv | 10.1023/A:1020695902160 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_807278140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18583333</sourcerecordid><originalsourceid>FETCH-LOGICAL-c343t-fa14f4fa9a9994be7a37e136447c7c847384b499d25ae6e265365dfc916a25ba3</originalsourceid><addsrcrecordid>eNqF0D1PwzAQBmALgWgpzGzIYoAp4G_HbFUFBamIAZgjxzmLVElcYgep_54gysIAt9yd9Oik9xA6peSKEsav5zdjI8pIQxhVZA9NqdQsM8qYfTQlhPBMEc0m6CjG9bgaletDNKGMK8MIn6LHJXSQamebZovbUNW-hgo_px42Kbjg3BBxOyTbRexDj9Mb4E0PH9ClOnQ4eFyNo22ws30N8RgdeNtEONn1GXq9u31Z3Gerp-XDYr7KHBc8Zd5S4YW3xhpjRAnacg2UKyG00y4XmueiFMZUTFpQwJTkSlbeGaosk6XlM3T5fXfTh_cBYiraOjpoGttBGGKRj5l1TgUZ5cWfUjMqc6bVv5DmMudfNUPnv-A6DH03xi205NJQzdmIznZoKFuoik1ft7bfFj-P559jEYO6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>753591732</pqid></control><display><type>article</type><title>Genetically modified Streptococcus mutans for the prevention of dental caries</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Hillman, Jeffrey D</creator><creatorcontrib>Hillman, Jeffrey D</creatorcontrib><description>There are many examples of positive and negative interactions between different species of bacteria inhabiting the same ecosystem. This observation provides the basis for a novel approach to preventing microbial diseases called replacement therapy. In this approach, a harmless effector strain is permanently implanted in the host's microflora. Once established, the presence of the effector strain prevents the colonization or outgrowth of a particular pathogen. In the case of dental caries, replacement therapy has involved construction of an effector strain called BCS3-L1, which was derived from a clinical Streptococcus mutans isolate. Recombinant DNA technology was used to delete the gene encoding lactate dehydrogenase in BCS3-L1 making it entirely deficient in lactic acid production. This effector strain was also designed to produce elevated amounts of a novel peptide antibiotic called mutacin 1140 that gives it a strong selective advantage over most other strains of S. mutans. In laboratory and rodent model studies, BCS3-L1 was found to be genetically stable and to produce no apparent deleterious side effects during prolonged colonization. BCS3-L1 was significantly less cariogenic than wild-type S. mutans in gnotobiotic rats, and it did not contribute at all to the cariogenic potential of the indigenous flora of conventional Sprague-Dawley rats. And, its strong colonization properties indicated that a single application of the BCS3-L1 effector strain to human subjects should result in its permanent implantation and displacement over time of indigenous, disease-causing S. mutans strains. Thus, BCS3-L1 replacement therapy for the prevention of dental caries is an example of biofilm engineering that offers the potential for a highly efficient, cost effective augmentation of conventional prevention strategies. It is hoped that the eventual success of replacement therapy for the prevention of dental caries will stimulate the use of this approach in the prevention of other bacterial diseases.</description><identifier>ISSN: 0003-6072</identifier><identifier>EISSN: 1572-9699</identifier><identifier>DOI: 10.1023/A:1020695902160</identifier><identifier>PMID: 12369203</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>Acid production ; Animal models ; Bacteria ; Bacterial diseases ; Biofilms ; Colonization ; Dental caries ; Dental Caries - prevention & control ; DNA ; Fermentation ; Flora ; Gene Deletion ; Genetic Engineering ; Gnotobiotics ; Human subjects ; Humans ; L-Lactate dehydrogenase ; L-Lactate Dehydrogenase - genetics ; Lactic acid ; Microflora ; Pathogens ; Peptide antibiotics ; Prevention ; Side effects ; Streptococcus mutans ; Streptococcus mutans - genetics ; Streptococcus mutans - pathogenicity</subject><ispartof>Antonie van Leeuwenhoek, 2002-08, Vol.82 (1-4), p.361-366</ispartof><rights>Kluwer Academic Publishers 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c343t-fa14f4fa9a9994be7a37e136447c7c847384b499d25ae6e265365dfc916a25ba3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12369203$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hillman, Jeffrey D</creatorcontrib><title>Genetically modified Streptococcus mutans for the prevention of dental caries</title><title>Antonie van Leeuwenhoek</title><addtitle>Antonie Van Leeuwenhoek</addtitle><description>There are many examples of positive and negative interactions between different species of bacteria inhabiting the same ecosystem. This observation provides the basis for a novel approach to preventing microbial diseases called replacement therapy. In this approach, a harmless effector strain is permanently implanted in the host's microflora. Once established, the presence of the effector strain prevents the colonization or outgrowth of a particular pathogen. In the case of dental caries, replacement therapy has involved construction of an effector strain called BCS3-L1, which was derived from a clinical Streptococcus mutans isolate. Recombinant DNA technology was used to delete the gene encoding lactate dehydrogenase in BCS3-L1 making it entirely deficient in lactic acid production. This effector strain was also designed to produce elevated amounts of a novel peptide antibiotic called mutacin 1140 that gives it a strong selective advantage over most other strains of S. mutans. In laboratory and rodent model studies, BCS3-L1 was found to be genetically stable and to produce no apparent deleterious side effects during prolonged colonization. BCS3-L1 was significantly less cariogenic than wild-type S. mutans in gnotobiotic rats, and it did not contribute at all to the cariogenic potential of the indigenous flora of conventional Sprague-Dawley rats. And, its strong colonization properties indicated that a single application of the BCS3-L1 effector strain to human subjects should result in its permanent implantation and displacement over time of indigenous, disease-causing S. mutans strains. Thus, BCS3-L1 replacement therapy for the prevention of dental caries is an example of biofilm engineering that offers the potential for a highly efficient, cost effective augmentation of conventional prevention strategies. It is hoped that the eventual success of replacement therapy for the prevention of dental caries will stimulate the use of this approach in the prevention of other bacterial diseases.</description><subject>Acid production</subject><subject>Animal models</subject><subject>Bacteria</subject><subject>Bacterial diseases</subject><subject>Biofilms</subject><subject>Colonization</subject><subject>Dental caries</subject><subject>Dental Caries - prevention & control</subject><subject>DNA</subject><subject>Fermentation</subject><subject>Flora</subject><subject>Gene Deletion</subject><subject>Genetic Engineering</subject><subject>Gnotobiotics</subject><subject>Human subjects</subject><subject>Humans</subject><subject>L-Lactate dehydrogenase</subject><subject>L-Lactate Dehydrogenase - genetics</subject><subject>Lactic acid</subject><subject>Microflora</subject><subject>Pathogens</subject><subject>Peptide antibiotics</subject><subject>Prevention</subject><subject>Side effects</subject><subject>Streptococcus mutans</subject><subject>Streptococcus mutans - genetics</subject><subject>Streptococcus mutans - pathogenicity</subject><issn>0003-6072</issn><issn>1572-9699</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqF0D1PwzAQBmALgWgpzGzIYoAp4G_HbFUFBamIAZgjxzmLVElcYgep_54gysIAt9yd9Oik9xA6peSKEsav5zdjI8pIQxhVZA9NqdQsM8qYfTQlhPBMEc0m6CjG9bgaletDNKGMK8MIn6LHJXSQamebZovbUNW-hgo_px42Kbjg3BBxOyTbRexDj9Mb4E0PH9ClOnQ4eFyNo22ws30N8RgdeNtEONn1GXq9u31Z3Gerp-XDYr7KHBc8Zd5S4YW3xhpjRAnacg2UKyG00y4XmueiFMZUTFpQwJTkSlbeGaosk6XlM3T5fXfTh_cBYiraOjpoGttBGGKRj5l1TgUZ5cWfUjMqc6bVv5DmMudfNUPnv-A6DH03xi205NJQzdmIznZoKFuoik1ft7bfFj-P559jEYO6</recordid><startdate>200208</startdate><enddate>200208</enddate><creator>Hillman, Jeffrey D</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QO</scope><scope>7X8</scope></search><sort><creationdate>200208</creationdate><title>Genetically modified Streptococcus mutans for the prevention of dental caries</title><author>Hillman, Jeffrey D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c343t-fa14f4fa9a9994be7a37e136447c7c847384b499d25ae6e265365dfc916a25ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Acid production</topic><topic>Animal models</topic><topic>Bacteria</topic><topic>Bacterial diseases</topic><topic>Biofilms</topic><topic>Colonization</topic><topic>Dental caries</topic><topic>Dental Caries - prevention & control</topic><topic>DNA</topic><topic>Fermentation</topic><topic>Flora</topic><topic>Gene Deletion</topic><topic>Genetic Engineering</topic><topic>Gnotobiotics</topic><topic>Human subjects</topic><topic>Humans</topic><topic>L-Lactate dehydrogenase</topic><topic>L-Lactate Dehydrogenase - genetics</topic><topic>Lactic acid</topic><topic>Microflora</topic><topic>Pathogens</topic><topic>Peptide antibiotics</topic><topic>Prevention</topic><topic>Side effects</topic><topic>Streptococcus mutans</topic><topic>Streptococcus mutans - genetics</topic><topic>Streptococcus mutans - pathogenicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hillman, Jeffrey D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Biotechnology Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Antonie van Leeuwenhoek</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hillman, Jeffrey D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetically modified Streptococcus mutans for the prevention of dental caries</atitle><jtitle>Antonie van Leeuwenhoek</jtitle><addtitle>Antonie Van Leeuwenhoek</addtitle><date>2002-08</date><risdate>2002</risdate><volume>82</volume><issue>1-4</issue><spage>361</spage><epage>366</epage><pages>361-366</pages><issn>0003-6072</issn><eissn>1572-9699</eissn><abstract>There are many examples of positive and negative interactions between different species of bacteria inhabiting the same ecosystem. This observation provides the basis for a novel approach to preventing microbial diseases called replacement therapy. In this approach, a harmless effector strain is permanently implanted in the host's microflora. Once established, the presence of the effector strain prevents the colonization or outgrowth of a particular pathogen. In the case of dental caries, replacement therapy has involved construction of an effector strain called BCS3-L1, which was derived from a clinical Streptococcus mutans isolate. Recombinant DNA technology was used to delete the gene encoding lactate dehydrogenase in BCS3-L1 making it entirely deficient in lactic acid production. This effector strain was also designed to produce elevated amounts of a novel peptide antibiotic called mutacin 1140 that gives it a strong selective advantage over most other strains of S. mutans. In laboratory and rodent model studies, BCS3-L1 was found to be genetically stable and to produce no apparent deleterious side effects during prolonged colonization. BCS3-L1 was significantly less cariogenic than wild-type S. mutans in gnotobiotic rats, and it did not contribute at all to the cariogenic potential of the indigenous flora of conventional Sprague-Dawley rats. And, its strong colonization properties indicated that a single application of the BCS3-L1 effector strain to human subjects should result in its permanent implantation and displacement over time of indigenous, disease-causing S. mutans strains. Thus, BCS3-L1 replacement therapy for the prevention of dental caries is an example of biofilm engineering that offers the potential for a highly efficient, cost effective augmentation of conventional prevention strategies. It is hoped that the eventual success of replacement therapy for the prevention of dental caries will stimulate the use of this approach in the prevention of other bacterial diseases.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>12369203</pmid><doi>10.1023/A:1020695902160</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-6072 |
ispartof | Antonie van Leeuwenhoek, 2002-08, Vol.82 (1-4), p.361-366 |
issn | 0003-6072 1572-9699 |
language | eng |
recordid | cdi_proquest_miscellaneous_807278140 |
source | MEDLINE; SpringerNature Journals |
subjects | Acid production Animal models Bacteria Bacterial diseases Biofilms Colonization Dental caries Dental Caries - prevention & control DNA Fermentation Flora Gene Deletion Genetic Engineering Gnotobiotics Human subjects Humans L-Lactate dehydrogenase L-Lactate Dehydrogenase - genetics Lactic acid Microflora Pathogens Peptide antibiotics Prevention Side effects Streptococcus mutans Streptococcus mutans - genetics Streptococcus mutans - pathogenicity |
title | Genetically modified Streptococcus mutans for the prevention of dental caries |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T05%3A51%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetically%20modified%20Streptococcus%20mutans%20for%20the%20prevention%20of%20dental%20caries&rft.jtitle=Antonie%20van%20Leeuwenhoek&rft.au=Hillman,%20Jeffrey%20D&rft.date=2002-08&rft.volume=82&rft.issue=1-4&rft.spage=361&rft.epage=366&rft.pages=361-366&rft.issn=0003-6072&rft.eissn=1572-9699&rft_id=info:doi/10.1023/A:1020695902160&rft_dat=%3Cproquest_pubme%3E18583333%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=753591732&rft_id=info:pmid/12369203&rfr_iscdi=true |